MySkin Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

MySkin General Information

Description

Provider of skin microbiome contract analysis services intended to provide genome information of microorganisms. The company offers a range of services including skin kit, Metagenome analysis, and options analysis, enabling patients to receive an analysis and report on their microbiome by sending a skin sample.

Contact Information

Website
www.myskin.jp
Formerly Known As
TAK-Circulator
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • HiRAKU GATE 603, Todaimae
  • 2-3-10 Mukogaoka, Bunkyo-ku
  • Tokyo, 113-0033
  • Japan
+81
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Other Healthcare Services
Other Pharmaceuticals and Biotechnology
Parent Company
Corporate Office
  • HiRAKU GATE 603, Todaimae
  • 2-3-10 Mukogaoka, Bunkyo-ku
  • Tokyo, 113-0033
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MySkin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Nov-2026 Completed Generating Revenue
2. Seed Round 01-Sep-2019 Completed Generating Revenue
1. Corporate 02-Aug-2016 Completed Generating Revenue
To view MySkin’s complete valuation and funding history, request access »

MySkin Patents

MySkin Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026220914-A1 Tape for collecting genomic dna and skin-resident microorganism, method for analyzing genomic dna of animal and skin-resident microorganism on surface of skin of animal, method for analyzing methylation of genomic dna, and method for predicting biological age Pending 17-Apr-2025
JP-7037160-B1 A prophylactic or therapeutic agent for at least one cancer selected from the group consisting of pancreatic cancer, lung cancer, colon cancer, bile duct cancer and liver cancer, and the prophylactic or therapeutic agent for the cancer in combination with the agent. a method for screening a therapeutic agent, a combination drug containing the agent, and a preventive or therapeutic agent for cancer. Active 01-May-2020
JP-2022082537-A A prophylactic or therapeutic agent for at least one cancer selected from the group consisting of pancreatic cancer, lung cancer, colorectal cancer, bile duct cancer and liver cancer, and the prophylactic or therapeutic agent for the cancer in combination with the agent. a method for screening a therapeutic agent, a combination drug containing the agent, and a preventive or therapeutic agent for cancer. Pending 01-May-2020
EP-4137156-A1 Prophylactic or therapeutic agent for at least one type of cancer selected from group consisting of pancreatic cancer, lung cancer, colorectal cancer, biliary tract cancer and liver cancer, prophylactic or therapeutic agent for said cancer which is used in combination drug in combination with said agent, combination drug comprising said agents, and method for screening for prophylactic or therapeutic agent for cancer Pending 01-May-2020
EP-4137156-A4 Prophylactic or therapeutic agent for at least one type of cancer selected from group consisting of pancreatic cancer, lung cancer, colorectal cancer, biliary tract cancer and liver cancer, prophylactic or therapeutic agent for said cancer which is used in combination drug in combination with said agent, combination drug comprising said agents, and method for screening for prophylactic or therapeutic agent for cancer Pending 01-May-2020 C12N15/113
To view MySkin’s complete patent history, request access »

MySkin Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Nippon Shokubai Corporation Minority
Seibu Shinkin Capital Corporate Venture Capital Minority
To view MySkin’s complete investors history, request access »

MySkin FAQs

  • When was MySkin founded?

    MySkin was founded in 2014.

  • Where is MySkin headquartered?

    MySkin is headquartered in Tokyo, Japan.

  • What industry is MySkin in?

    MySkin’s primary industry is Biotechnology.

  • Is MySkin a private or public company?

    MySkin is a Private company.

  • What is MySkin’s current revenue?

    The current revenue for MySkin is .

  • Who are MySkin’s investors?

    Nippon Shokubai and Seibu Shinkin Capital have invested in MySkin.

  • When was MySkin acquired?

    MySkin was acquired on 01-Nov-2026.

  • Who acquired MySkin?

    MySkin was acquired by Varinos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process